170 related articles for article (PubMed ID: 37624685)
1. Effects of Replacing a Central Glycine Residue in GLP-1 on Receptor Affinity and Signaling Profile.
Brown KA; Gellman SH
Chembiochem; 2023 Nov; 24(21):e202300504. PubMed ID: 37624685
[TBL] [Abstract][Full Text] [Related]
2. Impact of Substitution Registry on the Receptor-Activation Profiles of Backbone-Modified Glucagon-like Peptide-1 Analogues.
Cary BP; Hager MV; Gellman SH
Chembiochem; 2019 Nov; 20(22):2834-2840. PubMed ID: 31172641
[TBL] [Abstract][Full Text] [Related]
3. Differential Responses of the GLP-1 and GLP-2 Receptors to N-Terminal Modification of a Dual Agonist.
Gibadullin R; Cary BP; Gellman SH
J Am Chem Soc; 2023 Jun; 145(22):12105-12114. PubMed ID: 37235770
[TBL] [Abstract][Full Text] [Related]
4. β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues.
Hager MV; Johnson LM; Wootten D; Sexton PM; Gellman SH
J Am Chem Soc; 2016 Nov; 138(45):14970-14979. PubMed ID: 27813409
[TBL] [Abstract][Full Text] [Related]
5. α-Helix or β-Turn? An Investigation into N-Terminally Constrained Analogues of Glucagon-like Peptide 1 (GLP-1) and Exendin-4.
Oddo A; Mortensen S; Thøgersen H; De Maria L; Hennen S; McGuire JN; Kofoed J; Linderoth L; Reedtz-Runge S
Biochemistry; 2018 Jul; 57(28):4148-4154. PubMed ID: 29877701
[TBL] [Abstract][Full Text] [Related]
6. Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1.
Hager MV; Clydesdale L; Gellman SH; Sexton PM; Wootten D
Biochem Pharmacol; 2017 Jul; 136():99-108. PubMed ID: 28363772
[TBL] [Abstract][Full Text] [Related]
7. Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide.
Chang R; Zhang X; Qiao A; Dai A; Belousoff MJ; Tan Q; Shao L; Zhong L; Lin G; Liang YL; Ma L; Han S; Yang D; Danev R; Wang MW; Wootten D; Wu B; Sexton PM
J Biol Chem; 2020 Jul; 295(28):9313-9325. PubMed ID: 32371397
[TBL] [Abstract][Full Text] [Related]
8. Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states.
Neidigh JW; Fesinmeyer RM; Prickett KS; Andersen NH
Biochemistry; 2001 Nov; 40(44):13188-200. PubMed ID: 11683627
[TBL] [Abstract][Full Text] [Related]
9. Identification of N-Terminally Diversified GLP-1R Agonists Using Saturation Mutagenesis and Chemical Design.
Longwell CK; Hanna S; Hartrampf N; Sperberg RAP; Huang PS; Pentelute BL; Cochran JR
ACS Chem Biol; 2021 Jan; 16(1):58-66. PubMed ID: 33307682
[TBL] [Abstract][Full Text] [Related]
10. A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics.
Gómez Santiago C; Paci E; Donnelly D
Biochem Biophys Res Commun; 2018 Mar; 498(2):359-365. PubMed ID: 29397068
[TBL] [Abstract][Full Text] [Related]
11. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB
Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452
[TBL] [Abstract][Full Text] [Related]
12. Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptor.
Johnson RM; Zhang X; Piper SJ; Nettleton TJ; Vandekolk TH; Langmead CJ; Danev R; Sexton PM; Wootten D
Biochem Biophys Res Commun; 2021 Nov; 578():84-90. PubMed ID: 34547628
[TBL] [Abstract][Full Text] [Related]
13. Hormone Analogues with Unique Signaling Profiles from Replacement of α-Residue Triads with β/γ Diads.
Gibadullin R; Kim TW; Tran LM; Gellman SH
J Am Chem Soc; 2023 Sep; 145(37):20539-20550. PubMed ID: 37697685
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
Runge S; Thøgersen H; Madsen K; Lau J; Rudolph R
J Biol Chem; 2008 Apr; 283(17):11340-7. PubMed ID: 18287102
[TBL] [Abstract][Full Text] [Related]
15. Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling.
Plisson F; Hill TA; Mitchell JM; Hoang HN; de Araujo AD; Xu W; Cotterell A; Edmonds DJ; Stanton RV; Derksen DR; Loria PM; Griffith DA; Price DA; Liras S; Fairlie DP
Eur J Med Chem; 2017 Feb; 127():703-714. PubMed ID: 27823886
[TBL] [Abstract][Full Text] [Related]
16. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.
Malavazos AE; Iacobellis G; Dozio E; Basilico S; Di Vincenzo A; Dubini C; Menicanti L; Vianello E; Meregalli C; Ruocco C; Ragni M; Secchi F; Spagnolo P; Castelvecchio S; Morricone L; Buscemi S; Giordano A; Goldberger JJ; Carruba M; Cinti S; Corsi Romanelli MM; Nisoli E
Eur J Prev Cardiol; 2023 Jun; 30(8):680-693. PubMed ID: 36799940
[TBL] [Abstract][Full Text] [Related]
17. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex.
Liang YL; Khoshouei M; Glukhova A; Furness SGB; Zhao P; Clydesdale L; Koole C; Truong TT; Thal DM; Lei S; Radjainia M; Danev R; Baumeister W; Wang MW; Miller LJ; Christopoulos A; Sexton PM; Wootten D
Nature; 2018 Mar; 555(7694):121-125. PubMed ID: 29466332
[TBL] [Abstract][Full Text] [Related]
18. A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
Johnson LM; Barrick S; Hager MV; McFedries A; Homan EA; Rabaglia ME; Keller MP; Attie AD; Saghatelian A; Bisello A; Gellman SH
J Am Chem Soc; 2014 Sep; 136(37):12848-51. PubMed ID: 25191938
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional diversity among agonist-bound states of the GLP-1 receptor.
Cary BP; Deganutti G; Zhao P; Truong TT; Piper SJ; Liu X; Belousoff MJ; Danev R; Sexton PM; Wootten D; Gellman SH
Nat Chem Biol; 2022 Mar; 18(3):256-263. PubMed ID: 34937906
[TBL] [Abstract][Full Text] [Related]
20. Search for alpha-helical propensity in the receptor-bound conformation of glucagon-like peptide-1.
Murage EN; Schroeder JC; Beinborn M; Ahn JM
Bioorg Med Chem; 2008 Dec; 16(23):10106-12. PubMed ID: 18952440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
